Fundraising FoxCatalytic Impact Foundation — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Concarloconcarlo.comin𝕏Mar 2017
Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers.
AI & Machine LearningBiotechHealthtechBrooklyn, US
Stacy Blain(Founder, CEO)inLisaMarie Casey(President and Manager)Dustin Mraz(Executive Board Member / Co-founder)
BoardJason Mraz(Executive Board Member)in
Co-investorsBioAdvanceCreative Destruction Lab (CDL)Raptor Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.